ArticleAngewandte Chemie (International ed. in English)2025
RETRACTION: Spider Eye Development Editing and Silk Fiber Engineering Using CRISPR-Cas.
Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pax6 homologs are required for patterning both visual systems of the daddy-longlegs Phalangium opilio.Molecular biology and evolution · 2026Article
Corrections and comments
- Retraction of
Authors and funding
0 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
retractionE. Santiago-Rivera and T. Scheibel, "Spider Eye Development Editing and Silk Fiber Engineering Using CRISPR-Cas," Angewandte Chemie International Edition 64, no. 25 (2025): e202502068, https://doi.org/10.1002/anie.202502068. The above article, published online on 13 April 2025 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors; the journal Editor-in-Chief, Frank Maass; the German Chemical Society; and Wiley-VCH GmbH. In ongoing studies using CRISPR-Cas in spiders, the authors performed additional tests on the knock-out (KO) as well as knock-in (KI) mutants in correspondence with geneticists specializing in the use of CRISPR-Cas. The authors were unable to confirm that the KO as well as the KI occurred at the intended place in the genome. As the results in this study cannot be verified, the article must therefore be retracted.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.